Muscle Pharm Corporation (MSLPQ)

[Madcowelixir]

Didn't they get the CEO Ryan memo that "Turnaround Complete"?

Special congratulations to CEO Ryan's friend Buck Wessel at Amerop as he is down nearly -50% since he bought his 2.2m shares from Arnold and the open market @ $2.15 in April and May.

That is better performance than Nelson Obus of Wynnefield though as he has 1.2m shares @ $6.49 and has been in since 2013. Nice job Nelson! Down -80% and sitting on dead money for almost 5 years as the S&P, Dow, NASDAQ and Russell 2000 are at all-time highs.

It takes a special kind of stupid to be down -80% over 5 years when the market is at all time highs.

This Schedule 13D is filed by the Wynnefield Reporting Persons.


The business address of the Wynnefield Reporting Persons is 450 Seventh Avenue, Suite 509, New York, New York 10123.


Item 3. Source and Amount of Funds or Other Consideration.

Item 3 of the Schedule 13D is hereby amended and restated as follows:

The securities reported in this Schedule 13D as directly beneficially owned by the Wynnefield Reporting Persons were acquired with funds of approximately $7,701,741 (including brokerage commissions). All such funds were provided from the working capital or personal funds of the Wynnefield Reporting Persons who directly beneficially own such securities.



WYNNEFIELD COMMENDS LEADERSHIP OF MUSCLEPHARM CEO

Expresses Approval of Current Strategic Direction

NEW YORK – November 22, 2016 – Wynnefield Capital and its affiliates (collectively, "Wynnefield"), stockholders of MusclePharm Corp. (OTCQB: MSLP) ("MusclePharm" or the "Company") with a 8.6% ownership interest, today filed an amended Schedule 13-D/A expressing its approval of the company’s current strategic direction under the leadership of Executive Chairman and Interim CEO Ryan Drexler.

Nelson Obus, President of Wynnefield, said “We applaud Ryan Drexler for his success in carrying out a complete overhaul of MusclePharm’s business plan and removing executives who made investment in the company a money-losing proposition for so long a period. By jettisoning a series of absurd licensing agreements that threatened MusclePharm’s survival, and other beneficial changes, the company is now approaching a positive free cash flow position. While this significant turnaround came at the steep cost of share dilution, we believe that the improvement in MusclePharm’s prospects creates a real opportunity for all shareholders to benefit in the future from Mr. Drexler’s value creation skills.”

About Wynnefield Capital, Inc.

Established in 1992, Wynnefield Capital, Inc. is a value investor specializing in U.S. small cap situations that have company or industry-specific catalysts.

********Don't forget that Nelson Obus already took a -$2.2m loss on MSLP stock when he bought above $9.xx in 2013 and sold CEO Ryan 400K shares initial stake in a private transaction in 2015 to secure Chairman position at MSLP @ $5.48

Nelson has lost over $7m on MSLP so far.......with no end in sight.